Back
Marinus Pharmaceuticals Vs. Seres Therapeutics Industry Stock Comparison
Sell
33
MRNS
Marinus Pharmaceuticals
Last Price:
0.31
Seasonality Move:
14.27%
Sell
25
MCRB
Seres Therapeutics
Last Price:
0.58
Seasonality Move:
-13.92%
Sell
33
Marinus Pharmaceuticals (MRNS)
is a Sell
Is Marinus Pharmaceuticals a Buy, Sell or Hold?
- The current Marinus Pharmaceuticals [MRNS] share price is $0.30. The Score for MRNS is 33, which is 34% below its historic median score of 50, and infers higher risk than normal.
- MRNS is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
25
Seres Therapeutics (MCRB)
is a Sell
Is Seres Therapeutics a Buy, Sell or Hold?
- The current Seres Therapeutics [MCRB] share price is $0.59. The Score for MCRB is 25, which is 50% below its historic median score of 50, and infers higher risk than normal.
- MCRB is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
MRNS Stock Price Chart
What is Marinus Pharmaceuticals's stock price today?
-
The Marinus Pharmaceuticals share price today is $0.30
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and MRNS is experiencing selling pressure, which indicates risk of future bearish movement.
MCRB Stock Price Chart
What is Seres Therapeutics's stock price today?
-
The Seres Therapeutics share price today is $0.59
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and MCRB is experiencing selling pressure, which indicates risk of future bearish movement.
MRNS Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.32 | Sell |
Relative Strength Index (14 RSI): | 24.73 | Sell |
Chaikin Money Flow: | -1713004 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (0.2 - 1.6) | Sell |
Bollinger Bands (100): | (0.85 - 1.73) | Sell |
MCRB Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.05 | Sell |
Relative Strength Index (14 RSI): | 27.93 | Sell |
Chaikin Money Flow: | -5154121 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (0.7 - 0.82) | Sell |
Bollinger Bands (100): | (0.74 - 1.12) | Sell |
MRNS Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 0.33 | Sell |
20-day SMA: | 0.7 | Sell |
50-day SMA: | 1.26 | Sell |
200-day SMA: | 3.4 | Sell |
8-day EMA: | 0.36 | Sell |
20-day EMA: | 0.64 | Sell |
50-day EMA: | 1.05 | Sell |
200-day EMA: | 2.93 | Sell |
MCRB Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 0.72 | Sell |
20-day SMA: | 0.76 | Sell |
50-day SMA: | 0.86 | Sell |
200-day SMA: | 0.92 | Sell |
8-day EMA: | 0.7 | Sell |
20-day EMA: | 0.75 | Sell |
50-day EMA: | 0.82 | Sell |
200-day EMA: | 1.16 | Sell |
Marinus Pharmaceuticals Earnings Growth & MRNS Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.22 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.62 per share, and an increase next year of $1.17 per share.
Seres Therapeutics Earnings Growth & MCRB Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.13 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.31 per share, and an increase next year of $0.18 per share.
Marinus Pharmaceuticals Technical Analysis
Oct 31 | Nov 1 | Nov 4 | Nov 5 | Nov 6 | Nov 7 | Nov 8 | Nov 11 | Nov 12 | Nov 13 | |
---|---|---|---|---|---|---|---|---|---|---|
Oct | Nov | |||||||||
31 | 01 | 04 | 05 | 06 | 07 | 08 | 11 | 12 | 13 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Seres Therapeutics Technical Analysis
Oct 31 | Nov 1 | Nov 4 | Nov 5 | Nov 6 | Nov 7 | Nov 8 | Nov 11 | Nov 12 | Nov 13 | |
---|---|---|---|---|---|---|---|---|---|---|
Oct | Nov | |||||||||
31 | 01 | 04 | 05 | 06 | 07 | 08 | 11 | 12 | 13 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |